AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox viruses
Authors: Griffith, TS Kawakita, M Tian, J Ritchey, J Tartaglia, J Sehgal, I Thompson, TC Zhao, WC Ratliff, TL
Citation: Ts. Griffith et al., Inhibition of murine prostate tumor growth and activation of immunoregulatory cells with recombinant canarypox viruses, J NAT CANC, 93(13), 2001, pp. 998-1007
In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer
Authors: Sukin, SW Chhikara, M Zhu, XH Ayala, G Aguilar, LK Smith, EO Miles, BJ Thompson, TC Kadmon, D Aguilar-Cordova, E
Citation: Sw. Sukin et al., In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer, MOL THER, 3(4), 2001, pp. 500-506
Enhanced therapeutic effect of HSV-tk plus GCV gene therapy and ionizing radiation for prostate cancer
Authors: Chhikara, M Huang, HX Vlachaki, MT Zhu, XH Teh, B Chiu, KJ Woo, S Berner, B Smith, EO Oberg, KC Aguilar, LK Thompson, TC Butler, EB Aguilar-Cordova, E
Citation: M. Chhikara et al., Enhanced therapeutic effect of HSV-tk plus GCV gene therapy and ionizing radiation for prostate cancer, MOL THER, 3(4), 2001, pp. 536-542
Combination gene therapy with adenoviral vector-mediated HSV-tk plus GCV and IL-12 in an orthotopic mouse model for prostate cancer
Authors: Nasu, Y Bangma, CH Hull, GW Yang, G Wang, J Shimura, S McCurdy, MA Ebara, S Lee, HM Timme, TL Thompson, TC
Citation: Y. Nasu et al., Combination gene therapy with adenoviral vector-mediated HSV-tk plus GCV and IL-12 in an orthotopic mouse model for prostate cancer, PROSTATE C, 4(1), 2001, pp. 44-55
Prostate-specific antigen response and systemic T cell activation after insitu gene therapy in prostate cancer patients failing radiotherapy
Authors: Miles, BJ Shalev, M Aguilar-Cordova, E Timme, TL Lee, HM Yang, G Adler, HL Kernen, K Pramudji, CK Satoh, T Gdor, Y Ren, CZ Ayala, G Wheeler, TM Butler, EB Kadmon, D Thompson, TC
Citation: Bj. Miles et al., Prostate-specific antigen response and systemic T cell activation after insitu gene therapy in prostate cancer patients failing radiotherapy, HUM GENE TH, 12(16), 2001, pp. 1955-1967
LAPSER1: a novel candidate tumor suppressor gene from 10q24.3
Authors: Cabeza-Arvelaiz, Y Thompson, TC Sepulveda, JL Chinault, AC
Citation: Y. Cabeza-arvelaiz et al., LAPSER1: a novel candidate tumor suppressor gene from 10q24.3, ONCOGENE, 20(46), 2001, pp. 6707-6717
Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22
Authors: Cabeza-Arvelaiz, Y Sepulveda, JL Lebovitz, RM Thompson, TC Chinault, AC
Citation: Y. Cabeza-arvelaiz et al., Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22, ONCOGENE, 20(31), 2001, pp. 4169-4179
Enhanced therapeutic effect of multiple injections of HSV-TK plus GCV genetherapy in combination with ionizing radiation in a mouse mammary tumor model
Authors: Vlachaki, MT Chhikara, M Aguilar, L Zhu, XH Chiu, KJ Woo, S Teh, BS Thompson, TC Butler, EB Aguilar-Cordova, E
Citation: Mt. Vlachaki et al., Enhanced therapeutic effect of multiple injections of HSV-TK plus GCV genetherapy in combination with ionizing radiation in a mouse mammary tumor model, INT J RAD O, 51(4), 2001, pp. 1008-1017
Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression
Authors: Shaker, MR Yang, G Timme, TL Park, SH Kadmon, D Ren, CZ Ji, XR Lee, HM Sehgal, I Anzano, M Sporn, MB Thompson, TC
Citation: Mr. Shaker et al., Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression, CLIN EXP M, 18(5), 2001, pp. 429-438
Gene therapy for prostate cancer
Authors: Shalev, M Thompson, TC Kadmon, D Ayala, G Kernen, K Miles, BJ
Citation: M. Shalev et al., Gene therapy for prostate cancer, UROLOGY, 57(1), 2001, pp. 8-16
Desmuslin, an intermediate filament protein that interacts with alpha-dystrobrevin and desmin
Authors: Mizuno, Y Thompson, TC Guyon, JR Lidov, HGW Brosius, M Imamura, M Ozawa, E Watkins, SC Kunkel, LM
Citation: Y. Mizuno et al., Desmuslin, an intermediate filament protein that interacts with alpha-dystrobrevin and desmin, P NAS US, 98(11), 2001, pp. 6156-6161
Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells
Authors: Li, LK Yang, G Ebara, S Satoh, T Nasu, Y Timme, TL Ren, CZ Wang, JX Tahir, SA Thompson, TC
Citation: Lk. Li et al., Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells, CANCER RES, 61(11), 2001, pp. 4386-4392
Secreted caveolin-1 stimulates cell survival/clonal growth and contributesto metastasis in androgen-insensitive prostate cancer
Authors: Tahir, SA Yang, G Ebara, S Timme, TL Satoh, T Li, LK Goltsov, A Ittmann, M Morrisett, JD Thompson, TC
Citation: Sa. Tahir et al., Secreted caveolin-1 stimulates cell survival/clonal growth and contributesto metastasis in androgen-insensitive prostate cancer, CANCER RES, 61(10), 2001, pp. 3882-3885
Wheat starch, gliadin, and the gluten-free diet
Authors: Thompson, TC
Citation: Tc. Thompson, Wheat starch, gliadin, and the gluten-free diet, J AM DIET A, 101(12), 2001, pp. 1456-1459
Molecular pathways underlying prostate cancer progression - The role of caveolin-1
Authors: Thompson, TC Timme, TL Li, LK Ren, CZ Goltsov, A Tahir, S Yang, G
Citation: Tc. Thompson et al., Molecular pathways underlying prostate cancer progression - The role of caveolin-1, CONT CANC R, 2001, pp. 267-277
Elevated caveolin-1 levels in African-American versus white-American prostate cancer
Authors: Yang, G Addai, J Ittmann, M Wheeler, TM Thompson, TC
Citation: G. Yang et al., Elevated caveolin-1 levels in African-American versus white-American prostate cancer, CLIN CANC R, 6(9), 2000, pp. 3430-3433
Effect of 13-cis-retinoic acid on serum prostate-specific antigen levels in patients with recurrent prostate cancer after radical prostatectomy
Authors: Shalev, M Thompson, TC Frolov, A Lippman, SM Hong, WK Fritsche, H Kadmon, D
Citation: M. Shalev et al., Effect of 13-cis-retinoic acid on serum prostate-specific antigen levels in patients with recurrent prostate cancer after radical prostatectomy, CLIN CANC R, 6(10), 2000, pp. 3845-3849
Prostate cancer gene therapy: Comparison of adenovirus-mediated expressionof interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines
Authors: Hull, GW McCurdy, MA Nasu, Y Bangma, CH Yuang, G Shimura, S Lee, HM Wang, JX Albani, J Ebara, S Sato, T Timme, TL Thompson, TC
Citation: Gw. Hull et al., Prostate cancer gene therapy: Comparison of adenovirus-mediated expressionof interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines, CLIN CANC R, 6(10), 2000, pp. 4101-4109
Absence of PTEN/MMAC1 pseudogene in mice
Authors: Kwabi-Addo, B Thompson, TC Ittmann, M
Citation: B. Kwabi-addo et al., Absence of PTEN/MMAC1 pseudogene in mice, DNA CELL B, 19(5), 2000, pp. 301-305
Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis
Authors: Timme, TL Goltsov, A Tahir, S Li, LK Wang, JX Ren, CZ Johnston, RN Thompson, TC
Citation: Tl. Timme et al., Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis, ONCOGENE, 19(29), 2000, pp. 3256-3265
Induction of human Cdc37 in prostate cancer correlates with the ability oftargeted Cdc37 expression to promote prostatic hyperplasia
Authors: Stepanova, L Yang, G DeMayo, F Wheeler, TM Finegold, M Thompson, TC Harper, JW
Citation: L. Stepanova et al., Induction of human Cdc37 in prostate cancer correlates with the ability oftargeted Cdc37 expression to promote prostatic hyperplasia, ONCOGENE, 19(18), 2000, pp. 2186-2193
Fenretinide therapy in prostate cancer: Effects on tissue and serum retinoid concentration
Authors: Thaller, C Shalev, M Frolov, A Eichele, G Thompson, TC Williams, RH Dillioglugil, O Kadmon, D
Citation: C. Thaller et al., Fenretinide therapy in prostate cancer: Effects on tissue and serum retinoid concentration, J CL ONCOL, 18(22), 2000, pp. 3804-3808
Differential expression of nuclear retinoid receptors in normal and malignant prostates
Authors: Lotan, Y Xu, XC Shalev, M Lotan, R Williams, R Wheeler, TM Thompson, TC Kadmon, D
Citation: Y. Lotan et al., Differential expression of nuclear retinoid receptors in normal and malignant prostates, J CL ONCOL, 18(1), 2000, pp. 116-121
Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene
Authors: Shalev, M Miles, BJ Thompson, TC Ayala, G Butler, EB Aguilar-Cordova, E Kadmon, D
Citation: M. Shalev et al., Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene, WORLD J URO, 18(2), 2000, pp. 125-129
Regulation of apoptosis in prostatic disease
Authors: Thompson, TC Yang, G
Citation: Tc. Thompson et G. Yang, Regulation of apoptosis in prostatic disease, PROSTATE, 2000, pp. 25-28
Risultati: 1-25 | 26-42